[Hemorheologic changes in ankylosing spondylitis].
In nineteen patients with a definite ankylosing spondylitis haemorheological parameters were measured: serum, plasma and whole blood viscosity, haematocrit, red cell flexibility and aggregation, fibrinogen and ESR. Compared to matched controls these variables were significantly altered in patients. The pathophysiological meaning of this finding is as yet unclear and needs further investigation.
D000328:Adult; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001799:Blood Sedimentation; D001809:Blood Viscosity; D004903:Erythrocyte Aggregation; D004907:Erythrocyte Deformability; D005260:Female; D005340:Fibrinogen / Q000378:metabolism; D006400:Hematocrit; D006801:Humans; D007213:Indomethacin / Q000627:therapeutic use; D008297:Male; D010894:Piroxicam; D012212:Rheology; D013167:Spondylitis, Ankylosing / Q000097:blood* / Q000188:drug therapy; D013843:Thiazines / Q000627:therapeutic use
D000893:Anti-Inflammatory Agents; D013843:Thiazines; D010894:Piroxicam; D005340:Fibrinogen; D007213:Indomethacin
Hämorheologische Veränderungen bei ankylosierender Spondylitis.